RxDoctor Payments Data

Adrianna Hyams, NP

Nurse Practitioner · Newburgh, INNPI 1386179695

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 391 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 40 manufacturers reported payments, led by AbbVie at 26.0% of the total. 2025 is the largest year on record at $2,271, 2.6 times the $881 reported in 2021. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,108in general payments, 2019–2025

Across 391 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$642
  • Bristol Myers Squibb$600
  • Takeda Pharmaceuticals U.S.A., Inc.$279
  • Teva Pharmaceuticals USA, Inc.$263
  • Gilead$240
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,94897%
  • Education$1603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,108 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024
$16,659
Medicare patients
134
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir12$230
Fluticasone Propionate15$141
Doxycycline Monohydrate18$135
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$120
Cephalexin13$61
Amoxicillin19$35
Prednisone15$26

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Newburgh

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →